Menu

Drought-tolerant corn trials underwater

Agribusiness giant Monsanto is finding out that it's difficult to conduct field trials of drought-resistant corn when it won't stop raining. The company hopes to launch a new line of corn seed that's been genetically engineered to thrive in drough conditions by 2013.

May 26, 2011
Bob Grant

CornAGRILIFETODAY, FLICKRAgribusiness giant Monsanto is finding out that it's difficult to conduct field trials of drought-resistant corn when it won't stop raining. The company hopes to launch a new line of corn seed that's been genetically engineered to thrive in drought conditions by 2013, with plans to distribute it royalty-free to impoverished African farmers. But rainy summers since 2008 in the US western Plains, where Monsanto is conducting field trials of the seed, have muddied results. "We had about three good years where we could do field trials in Kansas. It was nice and dry," Monsanto regulatory affairs manager Bill Reeves told the Des Moines Register. "And then it started raining."

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.